Company Filing History:
Years Active: 2010-2022
Title: Innovations and Contributions of Inventor Daniel C H Lin
Introduction
Daniel C H Lin is a notable inventor based in Redwood City, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific metabolic disorders. With a total of 4 patents to his name, Lin's work has the potential to impact the treatment of various health conditions.
Latest Patents
Among his latest patents, Lin has developed benzimidazole derivatives and their uses. This invention relates to inhibitors of Transient Receptor Potential Channel 6 (TRPC6) protein activity. The patent provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, along with pharmaceutical compositions comprising the compound and methods for manufacturing these compounds. Another significant patent focuses on methods of treating metabolic disorders using PLA2G12A polypeptides and PLA2G12A mutant polypeptides. This invention outlines methods for treating or ameliorating metabolic diseases, including type 2 diabetes mellitus, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, and diabetic nephropathy.
Career Highlights
Throughout his career, Daniel C H Lin has worked with prominent companies such as Amgen Inc. and Teijin Pharma Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.
Collaborations
Lin has collaborated with various professionals in his field, including Michelle Akerman and Jonathan B Houze. These collaborations have likely enhanced his research and development efforts.
Conclusion
Daniel C H Lin's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to improve the lives of many individuals suffering from metabolic disorders.